Avraham Barak alleges that Teva's board and officers must have approved the criminal activity that led to the penalty. At the end of last week, Teva Pharmaceuticals Industries (TASE: TEVA; NYSE: TEVA) announced that it had reached a settlement with the US Department of Justice and would pay penalties totaling $450 million, payable over six years, without admitting wrongdoing, to end lawsuits brought against it by the US authorities.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Teva drug
Contact Teva drug, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack